RAMM Pharma Corp.
RAMM
CNSX
| 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | 07/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -6.54M | -6.59M | -6.18M | -5.71M | -15.24M |
| Total Depreciation and Amortization | 847.90K | 885.70K | 975.00K | 991.90K | 1.07M |
| Total Amortization of Deferred Charges | 300.00 | -- | -- | -- | 13.90K |
| Total Other Non-Cash Items | 2.25M | 2.19M | 2.19M | 1.74M | 10.43M |
| Change in Net Operating Assets | -63.60K | 356.30K | -284.20K | -267.10K | -26.80K |
| Cash from Operations | -3.51M | -3.16M | -3.30M | -3.25M | -3.76M |
| Capital Expenditure | -57.40K | -48.30K | -50.40K | -45.90K | -7.80K |
| Sale of Property, Plant, and Equipment | 103.00K | 103.00K | 79.00K | 112.20K | 37.60K |
| Cash Acquisitions | -- | -- | -- | -- | -837.10K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 27.10K | 55.90K | 55.30K | 27.40K | 113.50K |
| Cash from Investing | 72.80K | 110.70K | 84.00K | 93.80K | -693.70K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -215.20K | -204.00K | -205.00K | -235.40K | -298.40K |
| Issuance of Common Stock | 1.50K | 1.50K | 1.50K | 1.50K | -- |
| Repurchase of Common Stock | -- | -120.70K | -120.70K | -176.20K | -176.20K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 8.50K | 4.60K | 100.00 | 100.00 | -32.40K |
| Cash from Financing | -151.00K | -237.20K | -241.40K | -305.20K | -378.20K |
| Foreign Exchange rate Adjustments | 20.20K | 10.40K | -600.00 | 10.70K | 20.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.57M | -3.27M | -3.46M | -3.45M | -4.81M |
